Is CRTX or QYLD a better dividend investment in 2026?

CRTX currently yields 102.56% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: CRTX offers higher current income.

What is the dividend yield difference between CRTX and QYLD?

CRTX has a forward dividend yield of 102.56% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 90.64 percentage points.

Home › Compare › CRTX vs QYLD

CRTX vs QYLD: Dividend Comparison 2026

CRTX yields 102.56% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CRTX wins by $4.30M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CRTX

● Live price

102.56%

Share price

$1.95

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.32M

Annual income

$1,481,817.76

Full CRTX calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — CRTX vs QYLD

📍 CRTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CRTX	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CRTX + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CRTX pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRTX

Annual income on $10K today (after 15% tax)

$8,717.95/yr

After 10yr DRIP, annual income (after tax)

$1,259,545.10/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, CRTX beats the other by $1,254,734.68/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRTX + QYLD for your $10,000?

CRTX: 50%QYLD: 50%

100% QYLD50/50100% CRTX

Portfolio after 10yr

$2.17M

Annual income

$743,738.54/yr

Blended yield

34.20%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on QYLD right now

CRTX

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Altman Z

-4.0

Piotroski

2/9

QYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRTX buys

QYLD buys

No recent congressional trades found for CRTX or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCRTXQYLD

Forward yield	102.56% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.32M	$25.4K ✓
Annual income after 10y	$1,481,817.76 ✓	$5,659.31
Total dividends collected	$3.87M	$27.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: CRTX vs QYLD ($10,000, DRIP)

Year	CRTX Portfolio	CRTX Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$20,956	$10,256.41	$10,352	$1,192.36	+$10.6K → CRTX
2	$42,511	$20,087.62	$10,830	$1,347.57	+$31.7K → CRTX
3	$83,570	$38,082.81	$11,460	$1,539.07	+$72.1K → CRTX
4	$159,386	$69,966.82	$12,275	$1,777.84	+$147.1K → CRTX
5	$295,256	$124,712.82	$13,323	$2,078.95	+$281.9K → CRTX
6	$531,835	$215,911.30	$14,667	$2,463.34	+$517.2K → CRTX
7	$932,535	$363,471.12	$16,396	$2,960.57	+$916.1K → CRTX
8	$1,593,439	$595,626.55	$18,631	$3,612.97	+$1.57M → CRTX
9	$2,656,155	$951,175.34	$21,548	$4,482.15	+$2.63M → CRTX
10	$4,323,904	$1,481,817.76	$25,398	$5,659.31	+$4.30M → CRTX

CRTX vs QYLD: Complete Analysis 2026

CRTX — Stock

Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Full CRTX Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this CRTX vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRTX vs SCHD CRTX vs JEPI CRTX vs O CRTX vs KO CRTX vs MAIN CRTX vs XYLD CRTX vs JEPQ CRTX vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.